- Home
- PRPH
as 06-27-2025 1:33pm EST
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 15.2M | IPO Year: | 1997 |
| Target Price: | N/A | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.22 - $4.33 | Next Earning Date: | 08-13-2025 |
| Revenue: | $5,845,000 | Revenue Growth: | -67.59% |
| Revenue Growth (this year): | 221.82% | Revenue Growth (next year): | N/A |
Latest ProPhase Labs Inc. (DE) News
PRPH Breaking Stock News: Dive into PRPH Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule
GlobeNewswire
2 days ago
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
MT Newswires
11 days ago
ProPhase Labs Announces Successful BE-Smart Test for Detecting Esophageal Cancer; Shares Rise Pre-Bell
GlobeNewswire
11 days ago
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer
GlobeNewswire
22 days ago
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
GuruFocus.com
a month ago
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges
GlobeNewswire
a month ago
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
GlobeNewswire
a month ago
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
Compare PRPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRPH ProPhase Labs Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.